Cardiac magnetic resonance imaging and endothelin-1: A step forward in the detection of microvascular obstruction;Resonancia magnética cardiaca y endotelina-1: Un nuevo paso en la detección de la obstrucción microvascular

Revista Espanola de Cardiologia

Volumn 64, Issue 2, 2011, Pages 89-91

  Wu, Edwin ^a   Izquierdo Gómez, María Manuela ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

BLOOD VESSEL OCCLUSION; HEART; MICROVASCULAR OBSTRUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

EID: 79951724949     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2010.09.006     Document Type: Article

References (15)

1. D.J. Pennell, U.P. Sechtem, C.B. Higgins, W.J. Manning, G.M. Pohost, and F.E. Rademakers Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report Eur Heart J. 25 2004 1940 1965
2. E. Wu, J. Ortiz, P. Tejedor, D.C. Lee, C. Bucciarelli-Ducci, and P. Kansal Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study Heart. 94 2008 730 736
3. C. Bucciarelli-Ducci, E. Wu, D.C. Lee, T.A. Holly, F.J. Klocke, and R.O. Bonow Contrast-enhanced cardiac magnetic resonance in the evaluation of myocardial infarction and myocardial viability in patients with ischemic heart disease Curr Probl Cardiol. 31 2006 128 1268
4. R.J. Kim, E. Wu, A. Rafael, E.L. Chen, M.A. Parker, and O. Simonetti The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med. 343 2000 1445 1453
5. K.C. Wu, E.A. Zerhouni, R.M. Judd, C.H. Lugo-Olivieri, L.A. Barouch, and S.P. Schulman Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction Circulation. 97 1998 765 772
6. A.N. Mather, T. Lockie, E. Nagel, M. Marber, D. Perera, and S. Redwood Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction J Cardiovasc Magn Reson. 11 2009 33
7. V. Hombach, O. Grebe, N. Merkle, S. Waldenmaier, M. Höher, and M. Kochs Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging Eur Heart J. 26 2005 549 557
8. R. Nijveldt, A.M. Beek, A. Hirsch, M.G. Stoel, M.B. Hofman, and V.A. Umans Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury J Am Coll Cardiol. 52 2008 181 189 (Pubitemid 351915778)
9. N.J. Verouden, J.D. Haeck, W.J. Kuijt, N. Van Geloven, K.T. Koch, and J.P. Henriques Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention Am J Cardiol. 105 2010 1047 1052
10. M. Neizel, S. Futterer, H. Steen, E. Giannitsis, L. Reinhardt, and D. Lossnitzer Predicting microvascular obstruction with cardiac troponin T after acute myocardial infarction: a correlative study with contrast-enhanced magnetic resonance imaging Clin Res Cardiol. 98 2009 555 562
11. X. Freixa, M. Heras, J.T. Ortiz, S. Argiró, E. Guasch, and A. Doltra Utilidad de la determinación de endotelina-1 en el infarto agudo de miocardio Rev Esp Cardiol. 64 2011 105 110
12. H.K. Yip, C.J. Wu, H.W. Chang, C.H. Yang, T.H. Yu, and Y.H. Chen Prognostic value of circulating levels of endothelin-1 in patients after acute myocardial infarction undergoing primary coronary angioplasty Chest. 127 2005 1491 1497
13. G. Niccoli, F. Burzotta, L. Galiuto, and F. Crea Myocardial no-reflow in humans J Am Coll Cardiol. 54 2009 281 292
14. L. Galiuto, A.N. DeMaria, U. Del Balzo, K. May-Newman, S.F. Flaim, and P.L. Wolf Ischemia-reperfusion injury at the microvascular level: treatment by endothelin A-selective antagonist and evaluation by myocardial contrast echocardiography Circulation. 102 2000 3111 3116
15. A.D. Singh, S. Amit, O.S. Kumar, M. Rajan, and N. Mukesh Cardioprotective effects of bosentan, a mixed endothelin type A and B receptor antagonist, during myocardial ischaemia and reperfusion in rats Basic Clin Pharmacol Toxicol. 98 2006 604 610